Status:
COMPLETED
The Model for End-Stage Liver Disease Sodium (MELD-Na) Score in Non-cirrhotic Patients With Gastric Cancer
Lead Sponsor:
Istanbul Training and Research Hospital
Conditions:
Gastric Cancer
Complication,Postoperative
Eligibility:
All Genders
18-80 years
Brief Summary
Gastric cancer is the fifth most common cancer worldwide. Gastrectomy with lymphadenectomy is still the most effective treatment modality, depending on the stage and location. Despite many radiologica...
Eligibility Criteria
Inclusion
- Patients undergoing gastrectomy due to gastric cancer
Exclusion
- Patients with pulmonary, hepatic and renal disfunctions,
- Patients with diagnosed with a different cancer in the last 5 years and
- Pregnant patients
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 5 2022
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT04791293
Start Date
December 1 2020
End Date
August 5 2022
Last Update
August 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Training and Research Hospital
Istanbul, Turkey (Türkiye), 34029